Related references
Note: Only part of the references are listed.Basic principles of tumor-associated regulatory T cell biology
Peter A. Savage et al.
TRENDS IN IMMUNOLOGY (2013)
The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma
K. Giannopoulos et al.
BRITISH JOURNAL OF CANCER (2012)
Properties of end-stage human T cells defined by CD45RA re-expression
Sian M. Henson et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Induction by lenalidomide and dexamethasone combination increases regulatory cells of patients with previously untreated multiple myeloma
Karthick Raja Muthu Raja et al.
LEUKEMIA & LYMPHOMA (2012)
Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
Michel Attal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
Philip L. McCarthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Interleukin-7 Influences FOXP3+CD4+ Regulatory T Cells Peripheral Homeostasis
Federico Simonetta et al.
PLOS ONE (2012)
Tumour Cell Generation of Inducible Regulatory T-Cells in Multiple Myeloma Is Contact-Dependent and Antigen-Presenting Cell-Independent
Sylvia Feyler et al.
PLOS ONE (2012)
Increased T Regulatory Cells Are Associated with Adverse Clinical Features and Predict Progression in Multiple Myeloma
Karthick Raja Muthu Raja et al.
PLOS ONE (2012)
Treatment With Lenalidomide Modulates T-Cell Immunophenotype and Cytokine Production in Patients With Chronic Lymphocytic Leukemia
Bang-Ning Lee et al.
CANCER (2011)
Lenalidomide Enhances Antigen-Specific Activity and Decreases CD45RA Expression of T Cells from Patients with Multiple Myeloma
Brigitte Neuber et al.
JOURNAL OF IMMUNOLOGY (2011)
Multiple myeloma: biology of the disease
Anuj Mahindra et al.
BLOOD REVIEWS (2010)
Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function
A. K. Gandhi et al.
CURRENT CANCER DRUG TARGETS (2010)
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
H. Quach et al.
LEUKEMIA (2010)
Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation
Emmanuel Clave et al.
BLOOD (2009)
CD4+CD25+FoxP3+ regulatory T cells are increased whilst CD3+CD4-CD8-αβTCR+ Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden
Sylvia Feyler et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia
Georg Aue et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4(+)Foxp3(+) T cells
M. C. Minnema et al.
LEUKEMIA (2009)
Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma
Oliver C. Goodyear et al.
BLOOD (2008)
Lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
Lei Wu et al.
CLINICAL CANCER RESEARCH (2008)
Phenotype and Function of Human T Lymphocyte Subsets: Consensus and Issues
Victor Appay et al.
CYTOMETRY PART A (2008)
FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with stage and survival
L. M. Gjerdrum et al.
LEUKEMIA (2007)
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Meletios Dimopoulos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America
Donna M. Weber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q-syndrome patients
Andrea Pellagatti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Lenalidomide and CC-4047 inhibit the proliferation of malignant B cells while expanding normal CD34+ progenitor cells
Dominique Verhelle et al.
CANCER RESEARCH (2007)
Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pretreated patients with chronic lymphocytic leukemia
Krzysztof Giannopoulos et al.
LEUKEMIA RESEARCH (2007)
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
Gaynor J. Bates et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients
Ashley M. Miller et al.
JOURNAL OF IMMUNOLOGY (2006)
TNF downmodulates the function of human CD4+CD25hi T-regulatory cells
X Valencia et al.
BLOOD (2006)
In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma
Marc Beyer et al.
BLOOD (2006)
Dysfunctional T regulatory cells in multiple myeloma
RH Prabhala et al.
BLOOD (2006)
Immunotherapy in multiple myeloma - possibility or probability?
SJ Harrison et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Central memory and effector memory T cell subsets: Function, generation, and maintenance
F Sallusto et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
T-cell receptor excision circles: a novel prognostic parameter for the outcome of transplantation in multiple myeloma patients
M Svaldi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Decreased effector memory CD45RA(+)CD62L(-) CD8(+) T cells and increased central memory CD45RA(-)CD62L(+) CD8(+) T cells in peripheral blood of rheumatoid arthritis patients
A Maldonado et al.
ARTHRITIS RESEARCH & THERAPY (2003)
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications
N Mitsiades et al.
BLOOD (2002)
Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells
L Gorelik et al.
NATURE MEDICINE (2001)
Skewed maturation of memory HIV-specific CD8 T lymphocytes
P Champagne et al.
NATURE (2001)
Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution
DC Douek et al.
LANCET (2000)
Share Paper
